The ETF Store Show

ETFs Simply a Better “Technology”?   |   April 25th, 2017

Recently, Inside ETFs CEO Matt Hougan referred to ETFs as a new technology.  Nate & Jason expand on this concept, explaining how new technologies typically have a way of delivering a better experience at a lower cost – which likely explains the billions of investor dollars pouring into ETFs.  Bill Belden, Managing Director at Guggenheim, highlights the BulletShares lineup of ETFs and offers his perspective on the current interest rate/credit environment.

Emerging Market Stocks Stage a Comeback   |   April 18th, 2017

After years of underperformance, emerging market stocks have begun surging ahead.  Nate & Conor explain several of the key drivers of this recent outperformance, along with the rationale for owning a longer-term allocation to emerging market stocks in a portfolio.  Kevin Carter, CEO of Big Tree Capital, offers his perspective on emerging markets and spotlights the Emerging Markets Internet & Ecommerce ETF (EMQQ).

World’s Cheapest ETF Portfolio   |   April 11th, 2017

Nate & Conor discuss’s “World’s Cheapest ETF Portfolio“, which offers exposure to six major asset classes for the cost of a Starbucks latte.  David Varadi, Director of Research at Blue Sky Asset Management, spotlights the QuantX suite of ETFs and explains the concept of “smarter beta”.

Why Jim Cramer’s Anti-ETF Take is Wrong   |   April 4th, 2017

CNBC’s Jim Cramer recently ranted against ETFs on his stock picking show, Mad Money.  Nate & Conor explain why this type of messaging from the mainstream financial media is not only misguided, but irresponsible.  Conor Platt, Co-Founder & CEO of Etho Capital, spotlights the Etho Climate Leadership U.S. ETF (ETHO) and discusses the growing appeal of socially responsible investing.

The Paradox of Skill   |   March 28th, 2017

Nate & Jason discuss an excellent Abnormal Returns piece on bracketology, active management, and the paradox of skill.  John Feyerer, V.P. Equity ETF Product Strategy at PowerShares, goes in-depth on smart beta, including spotlighting several popular PowerShares ETFs.

Revisiting Active Manager Underperformance   |   March 14th, 2017

With hard data easily accessible to every investor, the active versus passive management debate has, in many ways, been put to rest.  Nate & Conor revisit some of the most recent data in an attempt to see if anything has changed.  Christian Magoon, CEO of Amplify ETFs, spotlights the Amplify YieldShares CWP Dividend & Option Income ETF (DIVO).

Investing in Precious Metals Using ETFs   |   March 7th, 2017

Investing in precious metals has never been easier with the growth of ETFs.  Nate & Conor discuss the basics of owning precious metals in a portfolio and explain why precious metal ETFs are a compelling option.  Maxwell Gold, Director of Investment Strategy at ETF Securities, surveys the current precious metals landscape and offers his perspective on why owning precious metals can make sense.

Proposed Bitcoin & Marijuana ETFs Generate Intrigue, Controversy   |   February 28th, 2017

Two proposed ETFs, the Winklevoss Bitcoin Trust and the Emerging AgroSphere ETF, are currently in registration with the Securities & Exchange Commission.  Nate and Jason explain the backstories behind these ETFs and offer some perspective on their potential investment merit.  Maz Jadallah, CEO & Founder of AlphaClone, spotlights the AlphaClone International ETF and discusses the concept of “active indexing”.

Biotech Expert Brad Loncar Discusses Sector, ETFs   |   February 21st, 2017

Biotech industry expert Brad Loncar discusses his approach to investing in biotech stocks and key current drivers in the sector.  Brad also offers his perspective on broad-based biotech ETFs and explains the index behind the Loncar Cancer Immunotherapy ETF (CNCR).  Nate & Jason spotlight the First Trust NYSE Arca Biotechnology Index Fund (FBT).

David Botset Highlights Charles Schwab’s Low Cost Approach to Investing   |   February 14th, 2017

David Botset, V.P. Strategy & Product Development at Charles Schwab, discusses Schwab’s low cost ETF lineup and commission-free ETF platform.  Nate & Conor also provide an update on the DOL fiduciary rule and spotlight the Schwab U.S. Large-Cap ETF (SCHX).

Vanguard’s Rich Powers Talks Low Cost ETFs, ETF Growth   |   February 7th, 2017

Rich Powers, Head of ETF Product Management at Vanguard, explains Vanguard’s low cost positioning in ETFs, offers his perspective on ETF growth, and spotlights two popular Vanguard ETFs. Also, Nate & Conor discuss the latest surrounding the DOL fiduciary rule and its impact on ETFs.

Recapping World’s Largest ETF Conference   |   January 31st, 2017

Nate & Conor recap last week’s Inside ETFs conference, offering key takeaways and insights.  We also talk Dow 20k and spotlight the NuShares Enhanced Yield U.S. Aggregate Bond ETF (NUAG).

Using ETFs for Satellite Holdings   |   January 17th, 2017

With nearly 2,000 ETFs to choose from, finding the right ETFs for your investment portfolio has become increasingly difficult – particularly if you wish to own smaller, satellite holdings.  Nate & Conor offer some tips on how to sort through the vast array of options and steer clear of ETF “landmines”.  Also, Andrew Chanin, CEO of PureFunds, spotlights the PureFunds Solactive FinTech ETF (FINQ) and the PureFunds ETFx HealthTech ETF (IMED). CEO Dave Nadig Recaps ETFs in 2016, Looks Ahead to 2017   |   January 10th, 2017

Dave Nadig, CEO of, offers his perspective on another record-breaking year for ETFs and expands on several of’s 2017 ETF predictions.  Nate and Jason also explain the rise of bitcoin and spotlight the top performing ETF of 2016.

2017 Key Market Themes   |   January 3rd, 2017

To kick off the new year, Nate & Jason set the table for the show over the next several months and also discuss key market themes to watch for in 2017.  Kevin Quigg, Chief Strategist at ACSI Funds, spotlights the American Customer Satisfaction Core Alpha ETF (ACSI), which seeks to overweight exposure to companies with the most satisfied customers.